We are live on
!
Find out more
PAM
PVG Asset Management Portfolio holdings
AUM
$173M
1-Year Est. Return
64.51%
This Fund
S&P 500
This Quarter
Est. Return
+15.12%
1 Year Est. Return
+64.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.4M
AUM Growth
+$6.41M
(+28%)
Cap. Flow
+$3.56M
Cap. Flow
% of AUM
12.13%
Top 10 Holdings %
Top 10 Hldgs %
47.53%
Holding
67
New
21
Increased
16
Reduced
12
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$1.99M |
| 2 |
NEOS S&P 500 High Income ETF
SPYI
|
+$633K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$606K |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$438K |
| 5 |
ARK Autonomous Technology & Robotics ETF
ARKQ
|
+$422K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily S&P 500 Bear 1X ETF
SPDN
|
+$4.08M |
| 2 |
GAP
The Gap Inc
GAP
|
+$268K |
| 3 |
Fortress Biotech
FBIO
|
+$260K |
| 4 |
Conagra Brands
CAG
|
+$250K |
| 5 |
CKPT
Checkpoint Therapeutics
CKPT
|
+$215K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.26% |
| 2 | Technology | 14.06% |
| 3 | Industrials | 3.98% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Financials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pfizer
PFE
$143B
| $200K | 0.68% |
8,264
-3,370
| -29% | -$78.6K |
|
|
CHMI
52
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $135K | 0.46% |
+49,510
| New | +$144K |
|
53
American Eagle Outfitters
AEO
$2.88B
| $121K | 0.41% |
+12,546
| New | +$135K |
|
|
MGF
54
Aberdeen Government Markets Income Fund
MGF
$91.6M
| $94.3K | 0.32% |
+30,220
| New | +$93.2K |
|
55
BioAtla
BCAB
$5.46M
| $25.7K | 0.09% |
1,300
| – | – |
|
56
Altimmune
ALT
$552M
| – | – |
-14,025
| Closed | -$70.1K |
|
|
57
Conagra Brands
CAG
$6.94B
| – | – |
-9,389
| Closed | -$250K |
|
58
CalciMedica
CALC
$15.8M
| – | – |
-30,385
| Closed | -$58K |
|
|
CKPT
59
DELISTED
Checkpoint Therapeutics
CKPT
| – | – |
-53,125
| Closed | -$215K |
|
60
Genelux
GNLX
$132M
| – | – |
-29,150
| Closed | -$78.7K |
|
|
PIM
61
Franklin Master Intermediate Income Trust
PIM
$150M
| – | – |
-47,072
| Closed | -$156K |
|
|
62
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$221M
| – | – |
-351,871
| Closed | -$4.08M |
|
63
Vanda Pharmaceuticals
VNDA
$307M
| – | – |
-10,375
| Closed | -$47.6K |
|
|
GAP
64
The Gap Inc
GAP
$7.23B
| – | – |
-13,009
| Closed | -$268K |
|
Similar funds
IAAG
CTEF
KIM
MC
GRA
VWWMG
RPSM
BAM
PVG Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, PVG Asset Management held 67 positions worth $29.4M, up 28% from $23M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
PVG Asset Management deployed $3.56M of net new capital in Q2 2025, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was NEOS S&P 500 High Income ETF: 13,163 shares worth $662K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Fortress Biotech, an estimated $260K trimmed.
- PVG Asset Management's largest Q2 2025 buy was NEOS S&P 500 High Income ETF: 13,163 shares worth $662K.
- PVG Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2025, an estimated $1.99M increase.
- PVG Asset Management's biggest Q2 2025 reduction was Fortress Biotech, cutting an estimated $260K.
- PVG Asset Management fully exited Direxion Daily S&P 500 Bear 1X ETF in Q2 2025, selling an estimated $4.08M.
- PVG Asset Management's ten largest holdings make up 48% of its $29.4M portfolio in Q2 2025.
- PVG Asset Management opened 21 new positions and closed 9 in Q2 2025.
- PVG Asset Management's portfolio value rose 28% quarter-over-quarter to $29.4M.
Based on PVG Asset Management's 13F filing for Q2 2025, filed 2 Sep 2025.